Science Explorer Back to mapMap
Discussion
Researcher · Clalit Health Services · Israel

Doron Netzer

Doron Netzer publishes mostly in Infectious Diseases, Epidemiology and General Health Professions, on topics such as SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies and Poxvirus research and outbreaks.

ORCID 0009-0000-0466-7310 OpenAlex
World rank
#894,476
of 7,710,434 ranked researchers
Rank in Israel
#6,392
of 38,292
Works
76
Citations
3k
Citations per work
39.3
h-index
16
i10-index 24Top 35% in Infectious Diseases
Doron Netzer

What does Doron Netzer research?

Doron Netzer's work is mostly in Medicine (37%), Health Professions (8%), Biochemistry, Genetics and Molecular Biology (4%).

Everything else: 36 works · 47.7% of their workHealth Sciences: 34 works · 44.9% of their workMedicine: 28 works · 37.4% of their workInfectious Diseases: 17 works · 22.4% of their workEpidemiology: 7 works · 8.9% of their workEndocrinology, Diabetes and Metabolism: 5 works · 6.1% of their workHealth Professions: 6 works · 7.5% of their workGeneral Health Professions: 6 works · 7.5% of their workLife Sciences: 6 works · 7.4% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 3.7% of their workMolecular Biology: 3 works · 3.7% of their workImmunology and Microbiology: 3 works · 3.7% of their workVirology: 3 works · 3.7% of their workTHEIR WORKDoron Netzer76works
Life Sciences7%Health Sciences45%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else3647.7%
    1. Medicine2837.4%
    2. Health Professions67.5%
    1. Biochemistry, Genetics and Molecular Biology33.7%
    2. Immunology and Microbiology33.7%
  1. 1Infectious Diseases22% of their works
  2. 2Epidemiology9% of their works
  3. 3General Health Professions8% of their works
  4. 4Endocrinology, Diabetes and Metabolism6% of their works
  5. 5Virology4% of their works
  6. 6Molecular Biology4% of their works

Research topics

Which keywords describe Doron Netzer's research?

The keywords of their largest research topics: ACE2 Receptor, SARS-CoV-2, Epidemiology, Vaccine, Viral Transmission, Immune Response, Coronavirus and antibody.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 24 words, with their numbers
  1. ACE2 Receptor422 topics
  2. SARS-CoV-2422 topics
  3. Epidemiology354 topics
  4. Vaccine333 topics
  5. Viral Transmission312 topics
  6. Immune Response293 topics
  7. Coronavirus272 topics
  8. antibody231 topic
  9. spike protein231 topic
  10. Clinical Characteristics191 topic
  11. Thrombosis191 topic
  12. Infectious Diseases112 topics
  13. Monkeypox Virus81 topic
  14. Smallpox Vaccination81 topic
  15. COVID-19 Vaccine71 topic
  16. Vaccine Hesitancy71 topic
  17. COVID-1961 topic
  18. Herpes Zoster61 topic
  19. Herpesviruses61 topic
  20. Modeling61 topic
  21. Innate Memory51 topic
  22. Trained Immunity51 topic
  23. Circovirus41 topic
  24. Porcine Reproductive and Respiratory Syndrome Virus41 topic

Where does Doron Netzer work?

Doron Netzer's main affiliation in the publication record is Clalit Health Services, Israel.

How many publications and citations does Doron Netzer have?

OpenAlex counts 76 works and 2,990 citations for Doron Netzer, an h-index of 16, ranking #894,476 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Doron Netzer. Posts are plain text and can be reported.